{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:35:51Z","timestamp":1770143751937,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-024-00786-y","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T14:05:03Z","timestamp":1725631503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The subchronic toxicity of higher olefins in Han Wistar rats"],"prefix":"10.1186","volume":"25","author":[{"given":"Quan","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Penman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Carlos","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An R.","family":"Van Rompay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenny","family":"Kamelia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn","family":"Rooseboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Boogaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"786_CR1","unstructured":"American Chemistry Council. A comparison of the environmental performance of olefin and paraffin synthetic base fluids (SBF). 2006."},{"key":"786_CR2","unstructured":"Braun C. Experimental SIDS Initial Assessment Report for SIAM 19. Berlin, Germany; 2004. pp. 19\u201322."},{"key":"786_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/019262339702500109","volume":"25","author":"CC Capen","year":"1997","unstructured":"Capen CC. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol. 1997;25:39\u201348.","journal-title":"Toxicol Pathol"},{"key":"786_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1210\/edrv-12-2-135","volume":"12","author":"PG Curran","year":"1991","unstructured":"Curran PG, DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev. 1991;12:135\u201350.","journal-title":"Endocr Rev"},{"key":"786_CR5","volume-title":"Lange\u2019s handbook of chemistry","author":"JA Dean","year":"1999","unstructured":"Dean JA. Lange\u2019s handbook of chemistry. New york; London: McGraw-Hill, Inc.; 1999."},{"key":"786_CR6","unstructured":"ECHA. Oct-1-ene, EC number: 203-893-7| CAS number: 111-66-0. Vol. 04-Apr-2023. ECHA; 2023."},{"key":"786_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/0192623310374332","volume":"38","author":"D Ennulat","year":"2010","unstructured":"Ennulat D, et al. Effects of hepatic drug-metabolizing enzyme induction on Clinical Pathology parameters in animals and man. Toxicol Pathol. 2010;38:810\u201328.","journal-title":"Toxicol Pathol"},{"key":"786_CR8","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/0009-2509(81)80161-3","volume":"36","author":"G Froment","year":"1981","unstructured":"Froment G. Thermal cracking for olefins production. Fundamentals and their application to industrial problems. Chem Eng Sci. 1981;36:1271\u201382.","journal-title":"Chem Eng Sci"},{"key":"786_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1021\/tx00042a006","volume":"7","author":"PD Gorycki","year":"1994","unstructured":"Gorycki PD, Macdonald TL. The oxidation of Tetrasubstituted Alkenes by Cytochrome P450. Chem Res Toxicol. 1994;7:745\u201351.","journal-title":"Chem Res Toxicol"},{"key":"786_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/10408444.2022.2082269","volume":"52","author":"KO Goyak","year":"2022","unstructured":"Goyak KO, et al. Adverse outcome pathway (AOP): \u03b12u-globulin nephropathy and kidney tumors in male rats. Crit Rev Toxicol. 2022;52:345\u201357.","journal-title":"Crit Rev Toxicol"},{"key":"786_CR11","unstructured":"Greaves P. Histopathology of preclinical toxicity studies: interpretation and relevance in drug safety evaluation. Academic; 2011."},{"key":"786_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/0192623312448935","volume":"40","author":"AP Hall","year":"2012","unstructured":"Hall AP, et al. Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes\u2013conclusions from the 3rd International ESTP Expert Workshop. Toxicol Pathol. 2012;40:971\u201394.","journal-title":"Toxicol Pathol"},{"key":"786_CR13","volume-title":"Evaluation of certain food additives\u2013 seventy-sixth report of the Joint FAO\/WHO Expert Committee on Food Additives","author":"JECFA","year":"2012","unstructured":"JECFA. Evaluation of certain food additives\u2013 seventy-sixth report of the Joint FAO\/WHO Expert Committee on Food Additives. Geneva: WHO; 2012."},{"key":"786_CR14","doi-asserted-by":"crossref","unstructured":"Lappin G. Alpha olefins applications handbook. CRC; 2014.","DOI":"10.1201\/9781482254259"},{"key":"786_CR15","first-page":"242","volume":"173","author":"KC Leibman","year":"1970","unstructured":"Leibman KC, Ortiz E. Epoxide intermediates in microsomal oxidation of olefins to glycols. J Pharmacol Exp Ther. 1970;173:242\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"786_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/10408444.2022.2130166","volume":"52","author":"MS Marty","year":"2022","unstructured":"Marty MS, et al. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny\u2014part III: how is substance-mediated thyroid hormone imbalance in pregnant\/lactating rats or their progeny related to neurodevelopmental effects? Crit Rev Toxicol. 2022;52:546\u2013617.","journal-title":"Crit Rev Toxicol"},{"key":"786_CR17","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1016\/S0021-9258(18)62746-2","volume":"245","author":"E Maynert","year":"1970","unstructured":"Maynert E, et al. Epoxides as obligatory intermediates in the metabolism of olefins to glycols. J Biol Chem. 1970;245:5234\u20138.","journal-title":"J Biol Chem"},{"key":"786_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/10408444.2015.1016216","volume":"45","author":"RH McKee","year":"2015","unstructured":"McKee RH, et al. Characterization of the toxicological hazards of hydrocarbon solvents. Crit Rev Toxicol. 2015;45:273\u2013365.","journal-title":"Crit Rev Toxicol"},{"key":"786_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/10408444.2023.2231033","volume":"53","author":"S Melching-Kollmuss","year":"2023","unstructured":"Melching-Kollmuss S, et al. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part IV: the ECETOC and CLE proposal for a thyroid function-related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS). Crit Rev Toxicol. 2023;53:339\u201371.","journal-title":"Crit Rev Toxicol"},{"key":"786_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"Mullur R, et al. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94:355\u201382.","journal-title":"Physiol Rev"},{"key":"786_CR21","volume-title":"Guideline 408. Subchronic oral toxicity\u2013 rodent: 90 day study (10 pages; adopted 21 September 1998)","author":"OECD","year":"1998","unstructured":"OECD. Guideline 408. Subchronic oral toxicity\u2013 rodent: 90\u00a0day study (10 pages; adopted 21 September 1998). Paris: Organisation for Economic Cooperation & Development; 1998."},{"key":"786_CR22","unstructured":"OECD. SIDS initial assessment report for Alpha Olefins Category 11 th SIAM. UNEP; 2001."},{"key":"786_CR23","first-page":"128","volume":"18","author":"PR Ortiz de Montellano","year":"1980","unstructured":"Ortiz de Montellano PR, Mico BA. Destruction of cytochrome P-450 by ethylene and other olefins. Mol Pharmacol. 1980;18:128\u201335.","journal-title":"Mol Pharmacol"},{"key":"786_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/10408444.2019.1694862","volume":"49","author":"R Pirow","year":"2019","unstructured":"Pirow R, et al. Mineral oil in food, cosmetic products, and in products regulated by other legislations. Crit Rev Toxicol. 2019;49:742\u201389.","journal-title":"Crit Rev Toxicol"},{"key":"786_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/10408444.2020.1839380","volume":"50","author":"UG Sauer","year":"2020","unstructured":"Sauer UG, et al. Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part I: which parameters from human studies are most relevant for toxicological assessments? Crit Rev Toxicol. 2020;50:740\u201363.","journal-title":"Crit Rev Toxicol"},{"key":"786_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/catal9030259","volume":"9","author":"WD Shafer","year":"2019","unstructured":"Shafer WD, et al. Fischer\u2013Tropsch: product selectivity\u2013the fingerprint of synthetic fuels. Catalysts. 2019;9:259.","journal-title":"Catalysts"},{"key":"786_CR27","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1021\/acs.chemrestox.2c00089","volume":"35","author":"Q Shi","year":"2022","unstructured":"Shi Q, et al. Assessment of the intestinal absorption of higher olefins by the Everted Gut Sac Model in Combination with in silico new approach methodologies. Chem Res Toxicol. 2022;35:1383\u201392.","journal-title":"Chem Res Toxicol"},{"key":"786_CR28","doi-asserted-by":"crossref","unstructured":"Shi Q et al. Toxicological assessment of higher Olefins in OECD TG 422 repeated dose and reproductive \/developmental toxicity screening tests in Han Wistar rats. Int J Toxicol. 2023:10915818231210856.","DOI":"10.1177\/10915818231210856"},{"key":"786_CR29","unstructured":"Springer ST. Toxicological evaluation of ethyl compound 100\u2013606. Vol. Study No. 413\u2013850 Gulf South Research Institute, New Iberia, LA, 1977, pp. Unpublished work."},{"issue":"6","key":"786_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1289\/ehp.93101s639","volume":"101","author":"JA Swenberg","year":"1993","unstructured":"Swenberg JA. Alpha 2u-globulin nephropathy: review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environ Health Perspect. 1993;101(6):39\u201344.","journal-title":"Environ Health Perspect"},{"key":"786_CR31","unstructured":"Swenberg JA, Lehman-McKeeman LD. 1999. Alpha 2-Urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats. IARC Sci Publ. 95\u2013118."},{"key":"786_CR32","volume-title":"Sub-chronic (90-day) oral toxicity study with octene-1 in rats","author":"HP Til","year":"1986","unstructured":"Til HP. Sub-chronic (90-day) oral toxicity study with octene-1 in rats. Beek, The Netherlands: Civo Institutes TNO; 1986."},{"key":"786_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1124\/dmd.121.000498","volume":"50","author":"NR Vansell","year":"2022","unstructured":"Vansell NR. Mechanisms by which inducers of drug metabolizing enzymes alter thyroid hormones in rats. Drug Metab Dispos. 2022;50:508\u201317.","journal-title":"Drug Metab Dispos"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00786-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-024-00786-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00786-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T14:06:34Z","timestamp":1725631594000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-024-00786-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1186\/s40360-024-00786-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies were designed and conducted to cause the minimum suffering or distress to the animals consistent with the scientific objectives and in accordance with the Harlan Laboratories Ltd, Shardlow, UK policy on animal welfare and the requirements of the United Kingdom\u2019s Animals (Scientific Procedure) Act 1986 Amendment Regulations 2012. The conduct of the study may be reviewed, as part of the Harlan Laboratories Ltd, Shardlow, UK Ethical Review Process. The studies were conducted in accordance with the UK Home Office Guidance document on Regulatory Toxicology and Safety Evaluation Studies and the OECD guidance document on recognition, assessment and use of clinical signs as humane endpoints for experimental animals used in safety evaluation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: The authors of this article are either employed by companies that manufacture petroleum products or consultants to those companies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}